home





























 


















 






















hrsa

participating institutions:
Johns Hopkins University AIDS Service, New York State DOH AIDS Institute, The CORE Center, Cook County Hospital



NEWS AND NEW DEVELOPMENTS



Initial Plasma HIV-1 RNA Levels and Progression to AIDS in Women and Men [Sterling TR, et al. NEJM 2001;344:720]: The investigators from Hopkins reviewed the sequential clinical features of HIV infection and correlated them with viral load tests done at six month intervals for a cohort of 156 men and 46 women injection drug users from 1988 through 1998. The results showed a median initial viral load of 50,766 c/mL in men compared to 15,103 c/mL in women (p < 0.001). The baseline CD4 cell counts were 659 and 672/mm3 for men and women, respectively. The risk of progression to AIDS was the same for men and women. The median initial viral load for those who progressed to AIDS was 77,822 c/mL for men and 17,149 c/mL for women. The authors note that the DHHS guidelines recommend antiretroviral agents for those with viral load >20,000 c/mL. On the basis of this recommendation, 74% of men and only 37% of women would have been candidates for these drugs despite the fact that the rate of progression was the same.
Comment: This report verifies several others that have addressed the issue of differences in viral load for men and women. There are three important observations that should be noted: First, CD4 cell counts seem to be comparable in the two groups and would serve as a reliable indicator for antiretroviral drugs. Secondly, the differences in viral load were greatest in the first few years after seroconversion, but these differences decreased during the subsequent course, so that they were far less pronounced at the time when decisions regarding antiretroviral drugs were likely to be made. Third, the DHHS guidelines were officially changed February 5, 2001, so that the threshold to initiate therapy was changed from 20,000 c/mL to 55,000 c/mL, and even then, the recommendation was qualified by the statement that many utilize the CD4 cell count to make the decision regarding initiation of antiretroviral treatment. Perhaps more intriguing is the biologic explanation for differences, which now seem well confirmed. To date, there is no clear reason for a difference, and the rate of progression from time of transmission appears to be the same.
p
osted 3/29/2001





Copyright © 2001. The National AIDS Education and Training Centers Program on behalf of its AETC National Resource Center. All rights reserved.

Physicians and other health care professionals are encouraged to consult other sources and confirm the information contained in this site because no single reference or service can take the place of medical training, education, and experience. Consumers are cautioned that this site is not intended to provide medical advice about any specific medical condition they may have or treatment they may need, and they are encouraged to call or see their physician or other health care provider promptly with any health related questions they may have.